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Hepatitis C virus (HCV), the major causative agent of non-A and non-B hepatitis, poses a serious worldwide
health problem. An estimated 100 million individuals worldwide are chronically infected with HCV. High
prevalence rates have been found in Southeast Asian countries, such as Thailand, Malaysia and India.1-3 Hepatitis C
is the most common chronic blood-borne infection in the U.S.4 In Pakistan, the seroprevalence of HCV is 6.7% in
women and 1.3% in children. Hepatitis C accounts for approximately 20% of cases of acute hepatitis, 70% of
chronic hepatitis and 30% of end-stage liver disease in the U.S.6
The hepatitis C virus is a single-stranded RNA virus of the Flaviviridae family. Individual isolates consist of a
closely related yet heterogeneous population of viral genomes (quasispecies). Probably as a consequence of this
genetic diversity, HCV has the ability to escape the host's immune surveillance, leading to a high rate of chronic
infection. The extensive genetic heterogeneity of HCV has important diagnostic and clinical implications, perhaps
explaining the variation in clinical course, difficulties in vaccine development, and lack of response to therapy.7
HCV is generally transmitted by the parenteral route. It is also transmitted by needle-stick injuries, sexual
contact, and vertically from mother to fetus.8 Hepatitis C exposure and antibody positivity rates among injection
drug users have been reported to be higher than 50% compared to 10% in the same general population. 9-12 Other
known risk factors include ear piercing, acupuncture, tattoos, and cultural procedures involving blood contact.13-15
The use of inadequately sterilized undisposable medical materials, e.g., needles and scalpels, has also been shown to
transmit HCV.16
There is some evidence of occupational and nosocomial transmission of HCV infection. Inadvertent needlestick injuries and lack of application of universal precautions may be contributing factors.15 About 80% of HCVpositive surgical operation room personnel in a hospital in Pakistan had more than four needle-stick injuries per year
in five years.17 In one Pakistani community, HCV seroprevalence was 6.5%, and individuals who received more
therapeutic injections were found to be at a higher risk of infection.18
Data on the natural history of HCV is limited because the onset of infection is often unrecognized, and the early
course of disease is indolent and protracted in most individuals.19 Approximately 60%-70% of HCV patients have
no discernable symptoms, 20%-30% may have jaundice, and 10%-20% may have nonspecific symptoms (e.g.,
anorexia, malaise, or abdominal pain). About 75%-85% go on to develop chronic hepatitis. Research indicates that
10%-20% of chronically infected individuals are likely to develop cirrhosis over a period of 20-30 years, while 1%5% may go on to develop hepatocellular carcinoma. Reports from Pakistan show that 22%-33% of biopsy-proven
cases of hepatocellular carcinoma had HCV infection.20,21
The volume of epidemiological data concerning hepatitis C is small compared with that concerning other
infectious diseases such as AIDS and hepatitis B. The few knowledge, attitude and practice (KAP) studies
concerning AIDS and hepatitis B have concluded that KAP concerning these diseases are severely deficient among
health care professionals. Awareness is particularly crucial in the case of hepatitis C as: 1) there is no vaccine
currently available (unlike hepatitis B);22 and 2) infected persons serve as a source of transmission to others and are
at a risk for chronic liver disease during the first two or three decades.4
Since surgical specialty residents have regular contact with HCV patients, they should be aware of the dangers
of the condition and the necessary precautions that need to be taken. Our study targeted this group of health care
personnel, as their knowledge, attitudes and practices are crucial in the management of HCV.
Subjects and Methods
Orthopedic trainee surgeons from three provinces and seven cities in Pakistan were surveyed. These residents
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are normally directly exposed to blood products and to incidents like needle pricks during the procedures they
participate in. Our aim was to determine the knowledge, attitude and practices of these health professionals.
Data collection was carried out using a self-administered, close-ended structured questionnaire. The
questionnaire was distributed to orthopedic surgery residents at the Annual Orthopedic Review Course in 1998 at
the Aga Khan University Hospital, Karachi. Only participants who were part of an orthopedic residency program at
the time were chosen. Respondents were given a 10-minute briefing on the aims of the study. One researcher was
present during the survey administration to answer queries raised by respondents. The administration of the
questionnaire lasted around half an hour.
All 43 residents except one were male. Their ages ranged from 26 to 43 years, with a median of 32.5 years. The
year of graduation was between 1980 and 1997, with a median year of 1990. The average number of years spent in
the orthopedic surgery program was four years.
Results
Level of Hepatitis C Knowledge
Only 16% of the surgical residents knew that there was a vaccine for hepatitis A. Though 84% knew that there
was no vaccine for hepatitis C, the majority (56%) were unaware that HCV was a sexually transmitted disease and
82% did not know about the possibility of it being transmitted perinatally. Of all the subjects, 93% knew that HCV
could be transmitted through blood transfusion and 88% knew about its transmission through a needle-stick injury.
As well, 65% did not know that HCV is initially asymptomatic. Knowledge about the complications of HCV was
adequate. Most of the residents were unaware of the physical properties of the virus, i.e., what destroys it, thus they
incorrectly estimated the seroconversion rates with exposure to patients. This finding correlates with another study.23
Overall, there were significant gaps in the knowledge of the hepatitis C virus transmission.
Practices Regarding Hepatitis C
Seventy-four percent of subjects had been vaccinated for HBV. This is an encouraging finding and was found to
be better than the vaccination prevalence of 59% in a Western study.23 When handling a known case of HCV, 87%
of subjects used an extra pair of gloves, while only 50% took extra care with needles. This particular finding is
consistent with their poor knowledge of the higher risk of infectivity of HCV with needle pricks. Most subjects used
two pairs of gloves except for minor surgeries. The median number of surgeries participated in was 12 in the
previous month, 150 in the previous year and 300 in the previous three years. The median number of needle pricks
was one in the previous month, three in the previous year and five in the previous three years. Only 16% of subjects
knew the serostatus of the patients they were pricked from, and only a similar number checked their own serology
after a needle-prick injury. The gravity of the situation is amplified by the fact that only 28% of the residents knew
their own serostatus for HCV compared to 60% for HBV. Another significant finding was that 60% of the trainee
surgeons were in habit of handling needles with their bare hands.
Attitudes
With regards to attitudes towards HCV, 42% of the respondents said they would tell their patients about their
own HCV seropositivity and 64% of residents did not believe in interferon therapy. Of all the respondents, 40%
were in a habit of reading medical literature at least once a week.
Discussion
The emergence of HCV as an important blood-borne pathogen compels us to focus our attention on protecting
health care workers from illness, disability or death.24 For surgeons, the prevalence of infection with HCV increases
with increasing age.25,26 Awareness of the dangers of this infectious disease should be instilled at an early stage of a
surgeon's training.
According to Johanet et al., out of 3554 operative procedures (visceral, orthopedic and vascular), 4% of
procedures were associated with percutaneous exposure of blood, and surgeons were involved in 51% of cases of
percutaneous exposure.27 HCV and HBV are more important than HIV as a cause of morbidity and death of
surgeons.28 The policy of standard precautions is not observed in all hospital operation theaters. The need to
implement standard precautions is reinforced by the fact that despite the knowledge of how to handle hepatitis C
patients, 49% of the respondents in one study could not avoid handling of blood. Similarly, handling needles with
bare hands shows a need for physician education in standard precautions against blood-borne diseases.
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The fact that only 16% of the subjects were in the habit of checking their own serology after a needle-prick
injury shows a lack of screening of both patient and victim, which should be a part of a hospital-wide protocol to be
followed after occupational exposure to blood and body fluids. The recommended protocol to be implemented is to
get baseline testing for anti-HCV for the source. For the person exposed to an HCV-positive source,
recommendations include baseline testing for anti-HCV and ALT activity, with follow-up tests for both at four to six
months. Confirmation by supplemental anti-HCV testing of all positive enzyme immunoassay results should be
done.4
In the light of the above results, changing the attitude of health care workers towards HCV becomes
increasingly important. We suggest that all new surgical residents who are at risk of exposure to blood should be
given a pre-test, a lecture, a demonstration of standard precautions and infection control procedures, followed by a
post-test. This approach has proven to be effective and is recommended.29 McCarthy et al. have emphasized that
orthopedic trauma surgeons need to improve their compliance with infection control recommendations.30 Further
efforts by the individuals and their institutions are warranted.
The risk of nosocomial transmission of HIV, HBV and other blood-borne pathogens can be minimized if
healthcare workers adopt the following general guidelines:4,31






Take care to prevent injuries when using needles, scalpels, and other sharp instruments or devices,
when handling sharp instruments after procedures, when cleaning used instruments, and when
disposing of used needles.
Do not recap used needles by hand; do not remove used needles from disposable syringes by hand, and
do not bend, break, or otherwise manipulate used needles by hand. Place used disposable syringes and
needles, scalpel blades, and other sharp items in puncture-resistant containers for disposal.
Use protective barriers to prevent exposure to blood, body fluids containing visible blood and other
fluids to which universal precautions apply. The type of protective barrier(s) should be appropriate for
the procedure being performed and the type of exposure anticipated.
Immediately and thoroughly wash hands and other skin surfaces that are contaminated with blood,
body fluids containing visible blood, or other body fluids to which universal precautions apply.
Use gloves for performing all phlebotomy procedures.
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